While Pfizer's dividend yield is clearly much higher than Merck's, both have relatively attractive yields today. And you ...

It might be prudent to make a point of collecting a little more cash in the near future, and worry a little less about growth ...

PFE Quantitative Stock Analysis June 03, 2025 — 09:36 am EDT. Written by John Reese for Validea-> Below is Validea's guru fundamental report for PFIZER INC . Of ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

A look at the shareholders of Pfizer Inc. (NYSE:PFE) can tell us which group is most powerful. The group holding the most ...

Shares are down in the year to date and 20% off their 52-week high, but analysts see 30% upside ahead for Pfizer.

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

Xtandi plus leuprolide improved overall survival in prostate cancer patients in the Phase 3 EMBARK trial, with no new safety ...

Concurrently, Pfizer released topline results from the final prespecified overall survival (OS) analysis of the TALAPRO-2 study of Talzenna (talazoparib) in combination with Xtandi (enzalutamide ...